Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06032546
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-09-05
Brief Title:
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus HIV Receiving Intravenous IV Infusion or Subcutaneous SC Injection of Budigalimab andor ABBV-382
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-05
First Submit QC Date:
September 5 2023
Study First Post Date:
2023-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL